Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Antispasmodic and Anticholinergic H2 Blocking Agents Market: By Drug Type: Natural, Semisynthetic Derivatives, Synthetic Compounds; By Indication; By Mode of Administration; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments

Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Outlook

The global antispasmodic and anticholinergic H2 blocking agents market is being driven by the rising anticholinergic drugs market. The anticholinergic drugs market is expected to grow at a CAGR of 4% in the forecast period of 2021-2026.

 

North America to be a Significant Regional Market for the Antispasmodic and Anticholinergic H2  Blocking Agents Industry

North America is a significant region in the global market for antispasmodic and anticholinergic H2 blocking agents, and the region is expected to remain a major market in the coming years as well. The growth in the region is primarily being driven by the growing medical sector. Europe and the Asia Pacific are also expected to emerge as major markets for antispasmodic and anticholinergic H2 blocking agents. The rapidly developing medical infrastructure and diagnostic facilities in emerging economies, such as China and India, and favourable care reimbursement policies are anticipated to boost the growth of the global demand for antispasmodic and anticholinergic H2 blocking agents.

 

Antispasmodic and Anticholinergic H2 Blocking Agents: Industry Definition and Segmentation

Antispasmodics and anticholinergics are a category of medicines, such as natural belladonna alkaloids, including belladonna, atropine, scopolamine, hyoscyamine, and other medications. Antispasmodics and anticholinergics are commonly used to alleviate cramps and spasms of the intestines, stomach, and bladder. These medications are used in conjunction with antacids and other medicines to treat ulcers, vomiting, nausea, and motion sickness. Antispasmodics and anticholinergic medications are also useful in the treatment of poisoning caused by various medicines, mushrooms, and organic pesticides.

Based on drug type, the industry can be divided into the following:

  • Natural
  • Semisynthetic Derivatives
  • Synthetic Compounds

On the basis of indication, the market can be segmented as follows:

  • Intestinal and Renal Colic Cramps
  • Diarrhoea
  • Spastic Constipation
  • Gastritis
  • Dysmenorrhea
  • Others

On the basis of mode of administration, the market can be divided as follows:

  • Oral
  • Parenteral
  • Topical
  • Others

The distribution channels can be categorised as follows:

  • Hospitals
  • Retail Pharmacies
  • Online
  • Others

The regional markets for antispasmodic and anticholinergic H2 blocking agents can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising Healthcare Sector Bolstering the Market Growth Antispasmodic and Anticholinergic H2 Blocking Agents

The growing availability of advanced diagnostic and treatment facilities for diseases including intestinal and renal colic cramps, diarrhoea, spastic constipation, gastritis, and dysmenorrhoea is a key factor that is expected to fuel the growth of the global market for antispasmodic and anticholinergic H2-blockers. Developing medical infrastructure and diagnostic facilities in emerging markets, such as China and India, and favourable care reimbursement policies are expected to strengthen the growth of the global demand for antispasmodic and anticholinergic H2 blocking agents. The rising research and development activities to introduce new and combined treatment technologies and update existing ones are also expected to drive the global demand for antispasmodic and anticholinergic H2 blocking agents in the forecast period.

 

Key Industry Players in the Global Antispasmodic and Anticholinergic H2 Blocking Agents Market

The report gives a detailed analysis of the following key players in the global antispasmodic and anticholinergic H2 blocking agents market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Sun Pharmaceutical Industries Ltd.
  • IriSys, LLC
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market (2016-2020) 
    8.3    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast (2021-2026)
    8.4    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Drug Type
        8.4.1    Natural
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Semisynthetic Derivatives
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Synthetic Compounds
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
    8.5    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Indication
        8.5.1    Intestinal and Renal Colic Cramps
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Diarrhoea
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Spastic Constipation
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Gastritis
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Dysmenorrhea
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2016-2020)
            8.5.5.3    Forecast Trend (2021-2026)
        8.5.6    Others
    8.6    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Mode of Administration
        8.6.1    Oral
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Parenteral
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Topical
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Others
    8.7    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Distribution Channel
        8.7.1    Hospitals
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Retail Pharmacies
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Online
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
        8.7.4    Others
    8.8    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles (*This list is only indicative. The report contains a more comprehensive list of players.)
        12.2.1    Sun Pharmaceutical Industries Ltd.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    IriSys, LLC
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market: Key Industry Highlights, 2016 and 2026
2.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Drug Type (USD Million), 2016-2020
3.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Drug Type (USD Million), 2021-2026
4.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Indication (USD Million), 2016-2020
5.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Indication (USD Million), 2021-2026
6.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Mode of Administration (USD Million), 2016-2020
7.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Mode of Administration (USD Million), 2021-2026
8.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Distribution Channel (USD Million), 2016-2020
9.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Distribution Channel (USD Million), 2021-2026
10.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Region (USD Million), 2016-2020
11.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Region (USD Million), 2021-2026
12.    North America Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2016-2020
13.    North America Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Europe Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Europe Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Asia Pacific Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Asia Pacific Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Latin America Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2016-2020
19.    Latin America Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2021-2026
20.    Middle East and Africa Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2016-2020
21.    Middle East and Africa Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2021-2026
22.    Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Structure

Key Questions Answered in the Report

The global antispasmodic and anticholinergic H2 blocking agents market is being aided by the anticholinergic drugs market, which is expected to grow at a CAGR of 4% between 2021 and 2026.

The growth of the industry is being driven by factors like the rising population, increased disposable incomes, rising health disorders, increasing availability of advanced diagnostic and treatment facilities, and the rising technological advancements.

The rising research and technological advancements are an important industry trend guiding the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading drug types in the market are natural, semisynthetic derivatives, and synthetic compounds.

The major indications segments in the industry are intestinal and renal colic cramps, diarrhoea, spastic constipation, gastritis, and dysmenorrhea, among others.

The significant modes of administration in the market are oral, parenteral, and topical, among others.

The major distribution channels in the industry are hospitals, retail pharmacies, and online, among others.

The major players in the industry are Sun Pharmaceutical Industries Ltd. and IriSys, LLC, among others.

Analyst Review

The global antispasmodic and anticholinergic H2 blocking agents market is being driven by the growing availability of advanced diagnostic and treatment facilities and the rising anticholinergic drugs market. Aided by the rising R&D activities, the anticholinergic drugs market is expected to witness a moderate growth in the forecast period of 2021-2026, growing at a CAGR of 4%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By drug type, the market is segmented into natural, semisynthetic derivatives, and synthetic compounds. Based on indication, the industry is divided into intestinal and renal colic cramps, diarrhoea, spastic constipation, gastritis, and dysmenorrhea, among others. On the basis of mode of administration, the industry is categorised into oral, parenteral, and topical, among others. By distribution channel, the market is segmented into hospitals, retail pharmacies, and online, among others. The major regional markets for antispasmodic and anticholinergic H2 blocking agents are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sun Pharmaceutical Industries Ltd. and IriSys, LLC, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Radiodermatitis Market Report and Forecast 2021-2026


Global Parkinson’s Disease Drugs Market Report and Forecast 2021-2026


Global Veterinary Drugs Market Report and Forecast 2021-2026


Global Cardiovascular Drugs Market Report and Forecast 2021-2026



NEWSLETTER